The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

Health Minister Aaron Motsoaledi says the newly approved anti-HIV injection, Lenacapavir, is a game-changer. He has welcomed the health products regulator's (SAHPRA) decision to approve the ...

A once-a-day pill has been proven to lower the risk of getting HIV among needle-using drug addicts, just as it does among heterosexual couples and men who have sex with men. Among 2,400 injecting drug ...

Today is the first National PrEP Day — a new annual event dedicated to spreading information and awareness around HIV prevention.

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.

Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...

Given that much of our coverage concerns gloomy topics like conflict, humanitarian crises and political discord, it always feels like a breath of fresh air when we’re able to spotlight a good-news ...

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot around R692 per person per year. We break down the ...

The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare's HIV drug, enabling ...

South Africa’s Health Product Regulatory Authority (SAHPRA) has approved the use of the twice-yearly HIV prevention drug, lenacapavir. In a statement released on 27 October, the regulatory body said ...

Most doctors agree Truvada is a boon in AIDS prevention; others express concern. July 16, 2012— -- The Food and Drug Adminstration today announced the approval of the first drug for use in people ...